Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Adomat

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The Prostate|March 10, 2009
A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancerJennifer A Locke, Ladan Fazli, Hans Adomat, et al.
Journal of Cellular Physiology|November 4, 2015
Identification of a Hematopoietic Cell Dedifferentiation-Inducing FactorYunyuan Li, Hans Adomat, Emma Tomlinson Guns, et al.
Nucleic Acids Research|May 15, 2020
G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stressSyam Prakash Somasekharan, Fan Zhang, Neetu Saxena, et al.
The Prostate|October 1, 2009
Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistanceJennifer A Locke, Emma S Tomlinson Guns, Melanie L Lehman, et al.
Journal of Cancer Research and Clinical Oncology|October 12, 2022
Extracellular vesicles from biological fluids as potential markers in castration resistant prostate cancerWendy W Y Choi, Catherine Sánchez, Jiao Jiao Li, et al.
EMBO Molecular Medicine|March 12, 2021
Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signalingNeetu Saxena, Eliana Beraldi, Ladan Fazli, et al.
Oncogene|April 10, 2025
Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Oncogene|January 3, 2023
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
BJU International|February 21, 2007
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomographyDonald T T Yapp, Janet Woo, Aileen Kartono, et al.
Molecular Cancer Therapeutics|August 14, 2013
Characterization of a new class of androgen receptor antagonists with potential therapeutic application in advanced prostate cancerHuifang Li, Mohamed D H Hassona, Nathan A Lack, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The Prostate|March 10, 2009
A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancerJennifer A Locke, Ladan Fazli, Hans Adomat, et al.
Journal of Cellular Physiology|November 4, 2015
Identification of a Hematopoietic Cell Dedifferentiation-Inducing FactorYunyuan Li, Hans Adomat, Emma Tomlinson Guns, et al.
Nucleic Acids Research|May 15, 2020
G3BP1-linked mRNA partitioning supports selective protein synthesis in response to oxidative stressSyam Prakash Somasekharan, Fan Zhang, Neetu Saxena, et al.
The Prostate|October 1, 2009
Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistanceJennifer A Locke, Emma S Tomlinson Guns, Melanie L Lehman, et al.
Journal of Cancer Research and Clinical Oncology|October 12, 2022
Extracellular vesicles from biological fluids as potential markers in castration resistant prostate cancerWendy W Y Choi, Catherine Sánchez, Jiao Jiao Li, et al.
EMBO Molecular Medicine|March 12, 2021
Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signalingNeetu Saxena, Eliana Beraldi, Ladan Fazli, et al.
Oncogene|April 10, 2025
Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Oncogene|January 3, 2023
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
BJU International|February 21, 2007
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with 18F-EF5 and positron emission tomographyDonald T T Yapp, Janet Woo, Aileen Kartono, et al.
Molecular Cancer Therapeutics|August 14, 2013
Characterization of a new class of androgen receptor antagonists with potential therapeutic application in advanced prostate cancerHuifang Li, Mohamed D H Hassona, Nathan A Lack, et al.
Pageof 7